- Home
- CLPR vs ECOR Comparison
CLPR vs ECOR Comparison
Compare CLPR & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPR | ECOR |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.8M | 49.1M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLPR | ECOR |
|---|---|---|
| Price | $3.50 | $6.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 65.2K | 64.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.45% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $109,997,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.82 | ★ 27.20 |
| 52 Week Low | $2.83 | $4.16 |
| 52 Week High | $4.61 | $8.55 |
Technical Indicators
Market Signals| Indicator | CLPR | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 48.60 |
| Support Level | $3.34 | $4.61 |
| Resistance Level | $3.60 | $6.61 |
| Average True Range (ATR) | 0.15 | 0.60 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 90.41 | 37.93 |
Price Performance
Historical ComparisonAbout CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.